From the start of the pandemic, our QA team was on top of newly emerging guidance

Monitoring regulatory guidance from global regulatory agencies was a regular activity for our quality assurance team which allowed us to keep up to date provisions for trial conduct. In addition to monitoring guidelines and Q&As, our team attended regulatory and ethics sessions to learn and apply requirements to ongoing and future clinical trials. 

Jane Gaviller-Fortune, Nutrasource's Director of Quality Assurance, explains just how we were able to quickly access new information and pivot to maintain GCP compliance.